Summary of GENOMIC HEALTH INC

Item 5.07 Submission of Matters to a Vote of Security
Holders.

The following actions were taken at the Annual Meeting of Stockholders of Genomic Health, Inc., held on June 7, 2012:

1. The following Directors were elected to serve until the 2013 Annual Meeting or until their successors are duly elected and qualified:

                                                         Broker
                                  For       Withheld    Non-Votes

Randal W. Scott, Ph.D.         24,264,897      62,609   2,634,887

Kimberly J. Popovits           24,067,121     260,385   2,634,887

Julian C. Baker                22,908,291   1,419,215   2,634,887

Fred E. Cohen, M.D., D.Phil.   24,269,060      58,446   2,634,887

Samuel D. Colella              23,960,747     366,759   2,634,887

Ginger L. Graham               24,269,134      58,372   2,634,887

Randall S. Livingston          24,258,359      69,147   2,634,887

Woodrow A. Myers, Jr., M.D.    23,967,030     360,476   2,634,887

2. The compensation of the Company's named executive officers was approved, on a non-binding advisory basis.

                                  Broker
   For       Against   Abstain   Non-Votes
23,949,663   363,556    14,287   2,634,887

3. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2012 fiscal year was approved.

For Against Abstain
26,863,690 76,181 22,522